BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1949172)

  • 1. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts.
    Ross J; He YG; Pidherney M; Mellon J; Niederkorn JY
    Transplantation; 1991 Nov; 52(5):857-61. PubMed ID: 1949172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response.
    Ross J; He YG; Niederkorn JY
    Curr Eye Res; 1991 Sep; 10(9):889-92. PubMed ID: 1790719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of donor Langerhans cells on corneal graft rejection.
    Niederkorn JY; Ross JR; He Y
    J Invest Dermatol; 1992 Nov; 99(5):104S-106S. PubMed ID: 1431197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of H-Y-disparate corneal grafts despite concomitant immunization of the recipient.
    He YG; Ross J; Callanan D; Niederkorn JY
    Transplantation; 1991 Jun; 51(6):1258-62. PubMed ID: 2048199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y; Streilein JW; Ksander BR
    Transplantation; 1999 Oct; 68(7):963-70. PubMed ID: 10532535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of rejected orthotopic corneal grafts in the rat.
    Callanan DG; Luckenbach MW; Fischer BJ; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):413-24. PubMed ID: 2647659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y; Ksander BR; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of rejection of orthotopic corneal allografts in the rat.
    Callanan D; Peeler J; Niederkorn JY
    Transplantation; 1988 Feb; 45(2):437-43. PubMed ID: 3278439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
    Wood KJ; Hopley A; Dallman MJ; Morris PJ
    Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival.
    Niederkorn JY
    Eye (Lond); 1995; 9 ( Pt 2)():215-8. PubMed ID: 7556720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.